Tenet Healthcare (NYSE:THC) Director J Robert Kerrey Sells 5,638 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tenet Healthcare Stock Up 0.9%

NYSE:THC opened at $174.83 on Friday. The company has a market cap of $15.06 billion, a PE ratio of 9.09, a P/E/G ratio of 1.14 and a beta of 1.30. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company’s 50 day moving average is $189.94 and its two-hundred day moving average is $201.87.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Analysts anticipate that Tenet Healthcare Corporation will post 17.67 EPS for the current year.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently modified their holdings of the business. WCM Investment Management LLC raised its position in shares of Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after buying an additional 362,083 shares during the last quarter. AlphaQuest LLC increased its position in Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after purchasing an additional 4,202 shares during the last quarter. Winnow Wealth LLC acquired a new stake in Tenet Healthcare during the third quarter worth about $1,129,000. Savant Capital LLC increased its position in Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after purchasing an additional 3,647 shares during the last quarter. Finally, Caption Management LLC acquired a new stake in Tenet Healthcare during the third quarter worth about $5,650,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

THC has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Wells Fargo & Company dropped their price objective on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Jefferies Financial Group upped their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Robert W. Baird dropped their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Finally, Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $244.16.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.